Ceramide-mediated Gut Dysbiosis Enhances Cholesterol Esterification and Promotes Colorectal Tumorigenesis in Mice

Overview

Journal JCI Insight

Specialties Biomedical Engineering
General Medicine

Date 2021 Dec 16

PMID 34914638

Citations 13

Authors

Yahui Zhu

Li Gu

Xi Lin

Jinmiao Zhang

Yi Tang

Xinyi Zhou

Bingjun Lu

Xingrong Lin

Cheng Liu

Edward V Prochownik

Youjun Li

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) severely threatens human health and life span. An effective therapeutic strategy has not been established because we do not clearly know its pathogenesis. Here, we report that ceramide and sterol O-acyltransferase 1 (SOAT1) have roles in both spontaneous and chemical-induced intestinal cancers. We first found that miRNA-148a deficiency dramatically increased mouse gut dysbiosis through upregulating ceramide synthase 5 (Cers5) expression, which promoted ceramide synthesis afterward. The newly generated ceramide further promoted both azoxymethane/dextran sodium sulfate-induced (AOM/DSS-induced) and ApcMin/+ spontaneous intestinal tumorigenesis via increasing mouse gut dysbiosis. Meanwhile, increased level of ceramide correlated with the significant enhancements of both β-catenin activity and colorectal tumorigenesis in a TLR4-dependent fashion. Next, we found a direct binding of β-catenin to SOAT1 promoter to activate transcriptional expression of SOAT1, which further induced cholesterol esterification and colorectal tumorigenesis. In human patients with CRC, the same CERS5/TLR4/β-catenin/SOAT1 axis was also found to be dysregulated. Finally, the SOAT1 inhibitor (avasimibe) showed significant levels of therapeutic effects on both AOM/DSS-induced and ApcMin/+ spontaneous intestinal cancer. Our study clarified that ceramide promoted CRC development through increasing gut dysbiosis, further resulting in the increase of cholesterol esterification in a SOAT1-dependent way. Treatment with avasimibe to specifically decrease cholesterol esterification could be considered as a clinical strategy for effective CRC therapy in a future study.

Citing Articles

Gasdermin D regulates the activation of EGFR in colorectal cancer.

Li Y, Chen J, Liang H, Du Q, Shen J, Wang X J Transl Med. 2024; 22(1):1170.

PMID: 39741309 PMC: 11687007. DOI: 10.1186/s12967-024-05984-0.

The diverse roles of sphingolipids in inflammatory bowel disease.

Doll C, Snider A FASEB J. 2024; 38(13):e23777.

PMID: 38934445 PMC: 467036. DOI: 10.1096/fj.202400830R.

The Role of Natural Products from Herbal Medicine in TLR4 Signaling for Colorectal Cancer Treatment.

Luo Y, Zhang G, Hu C, Huang L, Wang D, Chen Z Molecules. 2024; 29(12).

PMID: 38930793 PMC: 11206024. DOI: 10.3390/molecules29122727.

Comprehensive prognostic and immune analysis of sterol O-acyltransferase 1 in patients with hepatocellular carcinoma.

Gan C, Zheng Y, Yang B, Cao L World J Hepatol. 2024; 16(3):439-451.

PMID: 38577529 PMC: 10989313. DOI: 10.4254/wjh.v16.i3.439.

Therapeutic Potential for Sphingolipids in Inflammatory Bowel Disease and Colorectal Cancer.

Espinoza K, Snider A Cancers (Basel). 2024; 16(4).

PMID: 38398179 PMC: 10887199. DOI: 10.3390/cancers16040789.

References

Zhu Y, Gu L, Li Y, Lin X, Shen H, Cui K . miR-148a inhibits colitis and colitis-associated tumorigenesis in mice. Cell Death Differ. 2017; 24(12):2199-2209. PMC: 5686357. DOI: 10.1038/cdd.2017.151. View

Li J, Butcher J, Mack D, Stintzi A . Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease. Inflamm Bowel Dis. 2014; 21(1):139-53. DOI: 10.1097/MIB.0000000000000215. View

Schroeder B, Backhed F . Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016; 22(10):1079-1089. DOI: 10.1038/nm.4185. View

Ding L, Biswas S, Morton R, Smith J, Hay N, Byzova T . Akt3 deficiency in macrophages promotes foam cell formation and atherosclerosis in mice. Cell Metab. 2012; 15(6):861-72. PMC: 3372639. DOI: 10.1016/j.cmet.2012.04.020. View

Jung Y, Jun S, Kim M, Lee S, Suh H, Lien E . TMEM9 promotes intestinal tumorigenesis through vacuolar-ATPase-activated Wnt/β-catenin signalling. Nat Cell Biol. 2018; 20(12):1421-1433. PMC: 6261670. DOI: 10.1038/s41556-018-0219-8. View

Boulard O, Kirchberger S, Royston D, Maloy K, Powrie F . Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammation. J Exp Med. 2012; 209(7):1309-24. PMC: 3405508. DOI: 10.1084/jem.20120239. View

Kim Y, Lee E, Shin K, Kim M, Pewzner-Jung Y, Lee Y . Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases. Exp Mol Med. 2019; 51(11):1-16. PMC: 6825147. DOI: 10.1038/s12276-019-0340-1. View

Tsoi H, Chu E, Zhang X, Sheng J, Nakatsu G, Ng S . Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice. Gastroenterology. 2017; 152(6):1419-1433.e5. DOI: 10.1053/j.gastro.2017.01.009. View

Deng Y, Cai Z, Shi S, Jiang H, Shang Y, Ma N . Cilia loss sensitizes cells to transformation by activating the mevalonate pathway. J Exp Med. 2017; 215(1):177-195. PMC: 5748847. DOI: 10.1084/jem.20170399. View

10.

Yesudhas D, Gosu V, Anwar M, Choi S . Multiple roles of toll-like receptor 4 in colorectal cancer. Front Immunol. 2014; 5:334. PMC: 4097957. DOI: 10.3389/fimmu.2014.00334. View

11.

Walters W, Xu Z, Knight R . Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett. 2014; 588(22):4223-33. PMC: 5050012. DOI: 10.1016/j.febslet.2014.09.039. View

12.

Cleary J, Lipsky Z, Kim M, Marques C, German G . Heterogeneous ceramide distributions alter spatially resolved growth of on human stratum corneum. J R Soc Interface. 2018; 15(141). PMC: 5938579. DOI: 10.1098/rsif.2017.0848. View

13.

Wlodarska M, Thaiss C, Nowarski R, Henao-Mejia J, Zhang J, Brown E . NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell. 2014; 156(5):1045-59. PMC: 4017640. DOI: 10.1016/j.cell.2014.01.026. View

14.

Chen M, Yang L, Lu P, Fu X, Zhang Y, Zhu Y . MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells. Biochem Biophys Res Commun. 2015; 463(4):954-60. DOI: 10.1016/j.bbrc.2015.06.041. View

15.

Fitzgerald S, Sheehan K, Espina V, OGrady A, Cummins R, Kenny D . High CerS5 expression levels associate with reduced patient survival and transition from apoptotic to autophagy signalling pathways in colorectal cancer. J Pathol Clin Res. 2016; 1(1):54-65. PMC: 4858121. DOI: 10.1002/cjp2.5. View

16.

Burgueno J, Abreu M . Epithelial Toll-like receptors and their role in gut homeostasis and disease. Nat Rev Gastroenterol Hepatol. 2020; 17(5):263-278. DOI: 10.1038/s41575-019-0261-4. View

17.

Hu S, Peng L, Kwak Y, Tekippe E, Pasare C, Malter J . The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense. Cell Rep. 2015; 13(9):1922-36. PMC: 5477202. DOI: 10.1016/j.celrep.2015.10.040. View

18.

Nowarski R, Jackson R, Gagliani N, de Zoete M, Palm N, Bailis W . Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis. Cell. 2015; 163(6):1444-56. PMC: 4943028. DOI: 10.1016/j.cell.2015.10.072. View

19.

Cheng L, Zhu Y, Han H, Zhang Q, Cui K, Shen H . MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice. Cell Death Dis. 2017; 8(7):e2916. PMC: 5550856. DOI: 10.1038/cddis.2017.309. View

20.

Luo Y, Liu L, Li X, Shi Y . Avasimibe inhibits the proliferation, migration and invasion of glioma cells by suppressing linc00339. Biomed Pharmacother. 2020; 130:110508. DOI: 10.1016/j.biopha.2020.110508. View